Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meihua Lin

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
The Journal of Experimental Medicine|May 27, 2020
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolismQingxin Zhou, Meihua Lin, Xing Feng, et al.
Eclinicalmedicine|September 8, 2023
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trialQihan Fu, Yi Zheng, Weijia Fang, et al.
Bioactive Materials|November 21, 2025
Immunomodulatory copper-based polyphenol nanozyme for diabetic infectious wound healing via NIR amplified cuproptosis bacteriostat in synergy with ferroptosis inhibition anti-inflammationHuyang Gao, Juan Luo, Xixi Chen, et al.
Human Vaccines & Immunotherapeutics|July 15, 2017
Open-label phase I clinical trial of Ad5-EBOV in Africans in ChinaLihua Wu, Zhe Zhang, Hainv Gao, et al.
Autophagy|June 18, 2015
ATG16L1 phosphorylation is oppositely regulated by CSNK2/casein kinase 2 and PPP1/protein phosphatase 1 which determines the fate of cardiomyocytes during hypoxia/reoxygenationHuiwen Song, Jun Pu, Lin Wang, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
The Journal of Experimental Medicine|May 27, 2020
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolismQingxin Zhou, Meihua Lin, Xing Feng, et al.
Eclinicalmedicine|September 8, 2023
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trialQihan Fu, Yi Zheng, Weijia Fang, et al.
Bioactive Materials|November 21, 2025
Immunomodulatory copper-based polyphenol nanozyme for diabetic infectious wound healing via NIR amplified cuproptosis bacteriostat in synergy with ferroptosis inhibition anti-inflammationHuyang Gao, Juan Luo, Xixi Chen, et al.
Human Vaccines & Immunotherapeutics|July 15, 2017
Open-label phase I clinical trial of Ad5-EBOV in Africans in ChinaLihua Wu, Zhe Zhang, Hainv Gao, et al.
Autophagy|June 18, 2015
ATG16L1 phosphorylation is oppositely regulated by CSNK2/casein kinase 2 and PPP1/protein phosphatase 1 which determines the fate of cardiomyocytes during hypoxia/reoxygenationHuiwen Song, Jun Pu, Lin Wang, et al.
Pageof 11